744 related articles for article (PubMed ID: 26976734)
1. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
McIntosh K; Reed DE; Schneider T; Dang F; Keshteli AH; De Palma G; Madsen K; Bercik P; Vanner S
Gut; 2017 Jul; 66(7):1241-1251. PubMed ID: 26976734
[TBL] [Abstract][Full Text] [Related]
2. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
[TBL] [Abstract][Full Text] [Related]
3. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S
Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081
[TBL] [Abstract][Full Text] [Related]
4. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
[TBL] [Abstract][Full Text] [Related]
5. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
6. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
Nybacka S; Törnblom H; Josefsson A; Hreinsson JP; Böhn L; Frändemark Å; Weznaver C; Störsrud S; Simrén M
Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782
[TBL] [Abstract][Full Text] [Related]
7. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
[TBL] [Abstract][Full Text] [Related]
8. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
Varjú P; Farkas N; Hegyi P; Garami A; Szabó I; Illés A; Solymár M; Vincze Á; Balaskó M; Pár G; Bajor J; Szűcs Á; Huszár O; Pécsi D; Czimmer J
PLoS One; 2017; 12(8):e0182942. PubMed ID: 28806407
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.
Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R
Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338
[TBL] [Abstract][Full Text] [Related]
10. IBS randomized study: FODMAPs alter bile acids, phenolic- and tryptophan metabolites, while gluten modifies lipids.
Nordin E; Hellström PM; Vuong E; Ribbenstedt A; Brunius C; Landberg R
Am J Physiol Regul Integr Comp Physiol; 2023 Sep; 325(3):R248-R259. PubMed ID: 37399002
[TBL] [Abstract][Full Text] [Related]
11. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.
Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Simrén M
Gastroenterology; 2015 Nov; 149(6):1399-1407.e2. PubMed ID: 26255043
[TBL] [Abstract][Full Text] [Related]
12. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
Zahedi MJ; Behrouz V; Azimi M
J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
[TBL] [Abstract][Full Text] [Related]
13. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
[TBL] [Abstract][Full Text] [Related]
14. Diets that differ in their FODMAP content alter the colonic luminal microenvironment.
Halmos EP; Christophersen CT; Bird AR; Shepherd SJ; Gibson PR; Muir JG
Gut; 2015 Jan; 64(1):93-100. PubMed ID: 25016597
[TBL] [Abstract][Full Text] [Related]
15. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
Nordin E; Brunius C; Landberg R; Hellström PM
Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
[TBL] [Abstract][Full Text] [Related]
16. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.
Eswaran SL; Chey WD; Han-Markey T; Ball S; Jackson K
Am J Gastroenterol; 2016 Dec; 111(12):1824-1832. PubMed ID: 27725652
[TBL] [Abstract][Full Text] [Related]
18. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A
Digestion; 2016; 94(1):50-6. PubMed ID: 27487397
[TBL] [Abstract][Full Text] [Related]
19. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.
Hustoft TN; Hausken T; Ystad SO; Valeur J; Brokstad K; Hatlebakk JG; Lied GA
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27747984
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.
Ong DK; Mitchell SB; Barrett JS; Shepherd SJ; Irving PM; Biesiekierski JR; Smith S; Gibson PR; Muir JG
J Gastroenterol Hepatol; 2010 Aug; 25(8):1366-73. PubMed ID: 20659225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
